ACQC and AHF Dedicate Rockaway Beach HIV Healthcare and Service Center October 21st, 2026|Business Wire| ROCKAWAY BEACH, N.Y.–(BUSINESS WIRE)–ACQC and AHF Dedicate Rockaway Beach HIV Healthcare and Service Center Please leave this field empty Subscribe to Our Newsletter We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information. Please check your Inbox or Spam folder now to confirm your subscription. Like this post? Share it! FacebookXLinkedInEmail Related Posts Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting November 14th, 2026 | 0 Comments Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products November 13th, 2026 | 0 Comments Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 13th, 2026 | 0 Comments TherapeuticsMD Announces Third Quarter 2026 Financial Results November 13th, 2026 | 0 Comments Discount Finder Helps Customers Unlock More Prescription Savings November 13th, 2026 | 0 Comments Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026 November 13th, 2026 | 0 Comments Zai Lab Announces Participation in Investor Conferences in November 2026 November 13th, 2026 | 0 Comments Unified Women’s Healthcare Launches a New Initiative Aimed at Leveraging Routine OB/GYN Care to Identify Cardiovascular Risk Earlier and Connect More Women to Preventive Care November 13th, 2026 | 0 Comments Perioperative IMFINZI® (durvalumab) approved in the US in novel regimen with neoadjuvant enfortumab vedotin-ejfv for patients with muscle-invasive bladder cancer November 13th, 2026 | 0 Comments Inaugural Future of Oncology Summit Brings Together Leaders to Accelerate Cancer Innovation November 13th, 2026 | 0 Comments Revvity to Showcase Strategy for Powering Scientific Intelligence at 2026 Investor Day November 13th, 2026 | 0 Comments JAMA Network Open Publishes Quality of Life and Pain Outcomes Data from Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields for Pancreatic Cancer November 13th, 2026 | 0 Comments